The New YorkerHe told me, “We have this theory of nerd nation, of forty or fifty million people all over the world who believe that other nerds have more in common with them than the people in their own country. So you get to choose what tribe or band or group you … …read more
Tomorrow’s Advance Man – The New Yorker Read More »
Esperion Therapeutics’ (ESPR) CEO Tim Mayleben on Q1 2015 Results …Seeking AlphaWe currently have 22.5 million shares of common stock outstanding with another 2.5 million to be issued upon the exercise of options and warrants. Looking forward we estimate cash used in operating expenses for the full year 2015 to be approximately … and more
Esperion Therapeutics’ (ESPR) CEO Tim Mayleben on Q1 2015 Results … – Seeking Alpha Read More »
Freshpet’s (FRPT) CEO Richard Thompson on Q1 2015 Results – Earnings Call …Seeking AlphaAdjusting for fair value of warrants and stock-based compensation expense, SG&A expense decreased as a percentage of net sales to 51.3% from 58.8% in the same quarter last year. Looking ahead, we expect to further decrease … We would like to briefly
NewStar Financial’s (NEWS) CEO Tim Conway on Q1 2015 Results – Earnings …Seeking Alpha… our ability to compete effectively in a highly competitive industry, the market price of our common stock from time-to-time, and other investment opportunities available to us, and the impact of laws and regulations that govern non-depository … and more …read more
Amedica’s (AMDA) CEO Sonny Bal on Q1 2015 Results – Earnings Call …Seeking AlphaThey addressed the common myth in the marketplace that a material as stiff as silicon nitride ceramic could lead to subsidence. It does not. And it was …. This decline in expenses primarily due to $0.5 million decrease in stock-based compensation and
Amedica’s (AMDA) CEO Sonny Bal on Q1 2015 Results – Earnings Call … – Seeking Alpha Read More »
Marban Linda Just Bought Capricor Therapeutics Inc StakeOctaFinance.comThe Reporting Person may, from time to time, depending upon market conditions and other factors deemed relevantby the Reporting Person, acquire shares of common stock, preferred stock or warrants of the Issuer, outside of those contemplatedby the … …read more
Marban Linda Just Bought Capricor Therapeutics Inc Stake – OctaFinance.com Read More »
Investopedia… or $0.02 per share, to $10.5 million, or $0.08 per share. What was to blame for the sizable increase in its net loss? Primarily it was a huge gain experienced in 2014 from the revaluation of warrants. … Additionally, Galena shored up its balance …Stock Update (NASDAQ:GALE): Galena Biopharma Inc Reports First Quarter …Smarter
Galena Biopharma Earnings: NeuVax or Bust – Investopedia Read More »
Techsonian (press release)In addition, the Company will issue to the investors warrants to purchase 625,000 shares of common stock. The warrants have an exercise price of $10.00 per share and are exercisable for 30 months from the closing date. The offering is expected to close …Biotech Top gainers : PlasmaTech Biopharmaceuticals, Inc. (NASDAQ:PTBI …StreetWise Report
Pacific Road Resources Funds Announce Investment in Luna Gold Corp.The Northern Miner (subscription)(b) $20,000,000 aggregate principal amount of promissory notes (“Notes”) and 200,000,000 common share purchase warrants (each a “Series B Warrant”) for an aggregate purchase price of $20,000,000. Each Series B Warrant entitles the holder to purchase … and more …read more
Neuralstem Reports First Quarter 2015 Financial Results And Provides Business …Virtual Press Office (press release)The increase was primarily due to our raising approximately $6.0 million, net through the issuance of our common stock from warrant exercises and from the sale of our common stock largely offset by cash used in our operations. … first quarter